Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

Exclusion Criteria

• •* History of malaria or antimalarial drugs used in the last three months, as recalled or documented in health record
• •* Presence of severe malaria as defined by WHO guidelines at the moment of recruitment.
• •Presence of symptoms and signs of other serious chronic disease such as severe anaemia, tuberculosis and/or central nervous system infections, as defined by WHO guidelines